CliffBio
small molecule

ISOPTO ATROPINE

ATROPINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameISOPTO ATROPINE
Active ingredientATROPINE SULFATE
Strength1%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalDecember 2016
Marketing statusRX

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISOPTO ATROPINE patent cliff — loss of exclusivity — | CliffBio